| Organism name | Sesbania drummondii |
|---|---|
| Genus | Sesbania |
| Family | Fabaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Sesbania drummondii |
|---|---|
| Linked NCBI taxonomy ID | 206308 |
| Linked level | species |
| Family in NCBI taxonomy | Fabaceae |
|---|---|
| ID | 3803 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | rosids |
|---|---|
| ID | 71275 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00000701
|
Justicidin B
|
No. 285 | No. 21 |
|
||||
|
C00047211
|
Cycloheximide
|
CHEMBL123292
CHEMBL356004 CHEMBL225699 CHEMBL600517 CHEMBL582062 CHEMBL1078564 CHEMBL1358722 CHEMBL1552697 |
D003513
|
131 / 80 / 80 | 286 / 16 | No. 2705 |
|
|
|
C00018681
|
NSC 66645
/ Protomycin / Streptimidon / Streptimidone |
CHEMBL1981837
|
C005258
|
No. 4062 |
|
|||
|
C00043471
|
Drummondol
|
CHEMBL454176
|
C029812
|
No. 4252 |
|
|||
|
C00047352
|
Sesbanimide B
|
CHEMBL560362
CHEMBL1965002 |
No. 5600 |
|
||||
|
C00047351
|
Sesbanimide A
/ (+)-Sesbanimide A |
CHEMBL560362
CHEMBL1965002 |
C077293
|
No. 5600 |
|
|||
|
C00047353
|
Sesbanimide C
|
No. 5816 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00047211 | 1 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00047211 | 7 / 37 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00047211 | 4 / 1 |
| P17861 | X-box-binding protein 1 | Unclassified protein | C00047211 | 1 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00047211 | 0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | C00047211 | 1 / 1 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00047211 | 0 / 0 |
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00047211 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00047211 | 0 / 3 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00047211 | 2 / 2 |
| P08246 | Neutrophil elastase | S1A | C00047211 | 2 / 1 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00047211 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00047211 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00047211 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00047211 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00047211 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00047211 | 0 / 0 |
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00047211 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00047211 | 2 / 2 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00047211 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00047211 | 11 / 10 |
| P37840 | Alpha-synuclein | Unclassified protein | C00047211 | 4 / 2 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00047211 | 3 / 1 |
| P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00047211 | 0 / 0 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00047211 | 1 / 2 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00047211 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00047211 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00047211 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00047211 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00047211 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00047211 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00047211 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00047211 | 0 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00047211 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00047211 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00047211 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00047211 | 0 / 1 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00047211 | 1 / 8 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00047211 | 2 / 3 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00047211 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00047211 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00047211 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00047211 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00047211 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00047211 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00047211 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00047211 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00047211 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00047211 | 1 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00047211 | 0 / 0 |
| Q02790 | Peptidyl-prolyl cis-trans isomerase FKBP4 | Enzyme | C00047211 | 0 / 0 |
| Q00688 | Peptidyl-prolyl cis-trans isomerase FKBP3 | Enzyme | C00047211 | 0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00047211 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00047211 | 0 / 0 |
| P42858 | Huntingtin | Unclassified protein | C00047211 | 1 / 1 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00047211 | 2 / 0 |
| O75496 | Geminin | Unclassified protein | C00047211 | 0 / 0 |
| P51151 | Ras-related protein Rab-9A | Unclassified protein | C00047211 | 0 / 0 |
| P13639 | Elongation factor 2 | Unclassified protein | C00047211 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00047211 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00047211 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00047211 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00047211 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00047211 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00047211 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00047211 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00047211 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00047211 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00047211 | 0 / 0 |
| P10145 | Interleukin-8 | Secreted protein | C00047211 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00047211 | 1 / 0 |
| Q9Y237 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 | Enzyme | C00047211 | 0 / 0 |
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00047211 | 0 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00047211 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00047211 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00047211 | 1 / 0 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00047211 | 0 / 0 |
| Q9NWM8 | Peptidyl-prolyl cis-trans isomerase FKBP14 | Enzyme | C00047211 | 1 / 0 |
| P03956 | Interstitial collagenase | M10A | C00047211 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00047211 | 0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00047211 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00047211 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00047211 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00047211 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00047211 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00047211 | 2 / 0 |
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00047211 | 5 / 3 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00047211 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00047211 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00047211 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00047211 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00047211 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00047211 | 0 / 0 |
| Q96RI1 | Bile acid receptor | NR1H4 | C00047211 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00047211 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00047211 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00047211 | 2 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00047211 | 0 / 0 |
| P27540 | Aryl hydrocarbon receptor nuclear translocator | Unclassified protein | C00047211 | 0 / 0 |
| O15118 | Niemann-Pick C1 protein | Unclassified protein | C00047211 | 1 / 1 |
| P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00047211 | 0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00047211 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00047211 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00047211 | 1 / 1 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00047211 | 1 / 0 |
| P62942 | Peptidyl-prolyl cis-trans isomerase FKBP1A | Isomerase | C00047211 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00047211 | 1 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00047211 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00047211 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00047211 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00047211 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00047211 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00047211 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00047211 | 0 / 0 |
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00047211 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00047211 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00047211 | 0 / 1 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00047211 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00047211 | 0 / 0 |
| P10275 | Androgen receptor | NR3C4 | C00047211 | 3 / 4 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00047211 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00047211 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00047211 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00047211 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00047211 | 1 / 1 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00047211 | 0 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00047211 | 0 / 0 |
| P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00047211 | 0 / 0 |
| P68104 | Elongation factor 1-alpha 1 | Unclassified protein | C00047211 | 0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00047211 | 1 / 0 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00047211 | 1 / 1 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00047211
|
| 5244 | ABCB4, ABC21, GBD1, ICP3, MDR2, MDR2/3, MDR3, PFIC-3, PGY3 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44) |
C00047211
|
| 8714 | ABCC3, ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
C00047211
|
| 10057 | ABCC5, ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP, pABC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
C00047211
|
| 2181 | ACSL3, ACS3, FACL3, PRO2194 | acyl-CoA synthetase long-chain family member 3 (EC:6.2.1.3) |
C00047211
|
| 8754 | ADAM9, CORD9, MCMP, MDC9, Mltng | ADAM metallopeptidase domain 9 |
C00047211
|
| 133 | ADM, AM | adrenomedullin |
C00047211
|
| 136 | ADORA2B, ADORA2 | adenosine A2b receptor |
C00047211
|
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00047211
|
| 9495 | AKAP5, AKAP75, AKAP79, H21 | A kinase (PRKA) anchor protein 5 |
C00047211
|
| 9472 | AKAP6, ADAP100, ADAP6, AKAP100, PRKA6, mAKAP | A kinase (PRKA) anchor protein 6 |
C00047211
|
| 220 | ALDH1A3, ALDH1A6, ALDH6, MCOP8, RALDH3 | aldehyde dehydrogenase 1 family, member A3 (EC:1.2.1.5) |
C00047211
|
| 224 | ALDH3A2, ALDH10, FALDH, SLS | aldehyde dehydrogenase 3 family, member A2 (EC:1.2.1.3) |
C00047211
|
| 241 | ALOX5AP, FLAP | arachidonate 5-lipoxygenase-activating protein |
C00047211
|
| 248 | ALPI, IAP | alkaline phosphatase, intestinal (EC:3.1.3.1) |
C00047211
|
| 269 | AMHR2, AMHR, MISR2, MISRII, MRII | anti-Mullerian hormone receptor, type II (EC:2.7.11.30) |
C00047211
|
| 287 | ANK2, ANK-2, LQT4, brank-2 | ankyrin 2, neuronal |
C00047211
|
| 84079 | ANKRD27, VARP | ankyrin repeat domain 27 (VPS9 domain) |
C00047211
|
| 317 | APAF1, APAF-1, CED4 | apoptotic peptidase activating factor 1 |
C00047211
|
| 374 | AREG, AR, CRDGF, SDGF | amphiregulin |
C00047211
|
| 79798 | ARMC5 | armadillo repeat containing 5 |
C00047211
|
| 51665 | ASB1, ASB-1 | ankyrin repeat and SOCS box containing 1 |
C00047211
|
| 468 | ATF4, CREB-2, CREB2, TAXREB67, TXREB | activating transcription factor 4 |
C00047211
|
| 552 | AVPR1A, AVPR_V1a, AVPR1, V1aR | arginine vasopressin receptor 1A |
C00047211
|
| 8424 | BBOX1, BBH, BBOX, G-BBH, gamma-BBH | butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 (EC:1.14.11.1) |
C00047211
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00047211
|
| 598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00047211
|
| 79370 | BCL2L14, BCLG | BCL2-like 14 (apoptosis facilitator) |
C00047211
|
| 622 | BDH1, BDH, SDR9C1 | 3-hydroxybutyrate dehydrogenase, type 1 (EC:1.1.1.30) |
C00047211
|
| 8678 | BECN1, ATG6, VPS30, beclin1 | beclin 1, autophagy related |
C00047211
|
| 637 | BID, FP497 | BH3 interacting domain death agonist |
C00047211
|
| 672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset |
C00047211
|
| 675 | BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2 | breast cancer 2, early onset |
C00047211
|
| 90488 | C12orf23 | chromosome 12 open reading frame 23 |
C00047211
|
| 793 | CALB1, CALB | calbindin 1, 28kDa |
C00047211
|
| 819 | CAMLG, CAML | calcium modulating ligand |
C00047211
|
| 834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00047211
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00047211
|
| 837 | CASP4, ICE(rel)II, ICEREL-II, ICH-2, Mih1/TX, TX | caspase 4, apoptosis-related cysteine peptidase (EC:3.4.22.57) |
C00047211
|
| 840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00047211
|
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00047211
|
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00047211
|
| 857 | CAV1, BSCL3, CGL3, MSTP085, PPH3, VIP21, CAV | caveolin 1, caveolae protein, 22kDa |
C00047211
|
| 10951 | CBX1, CBX, HP1-BETA, HP1Hs-beta, HP1Hsbeta, M31, MOD1, p25beta | chromobox homolog 1 |
C00047211
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00047211
|
| 6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00047211
|
| 890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00047211
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00047211
|
| 22948 | CCT5, CCT-epsilon, CCTE, TCP-1-epsilon | chaperonin containing TCP1, subunit 5 (epsilon) |
C00047211
|
| 952 | CD38, T10 | CD38 molecule (EC:3.2.2.5) |
C00047211
|
| 916 | CD3E, T3E, TCRE | CD3e molecule, epsilon (CD3-TCR complex) |
C00047211
|
| 961 | CD47, IAP, MER6, OA3 | CD47 molecule |
C00047211
|
| 967 | CD63, LAMP-3, ME491, MLA1, OMA81H, TSPAN30 | CD63 molecule |
C00047211
|
| 925 | CD8A, CD8, Leu2, MAL, p32 | CD8a molecule |
C00047211
|
| 56990 | CDC42SE2, SPEC2 | CDC42 small effector 2 |
C00047211
|
| 113130 | CDCA5, SORORIN | cell division cycle associated 5 |
C00047211
|
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00047211
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00047211
|
| 1029 | CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16 | cyclin-dependent kinase inhibitor 2A |
C00047211
|
| 8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00047211
|
| 1128 | CHRM1, HM1, M1, M1R | cholinergic receptor, muscarinic 1 |
C00047211
|
| 10370 | CITED2, ASD8, MRG-1, MRG1, P35SRJ, VSD2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
C00047211
|
| 1182 | CLCN3, CLC3, ClC-3 | chloride channel, voltage-sensitive 3 |
C00047211
|
| 1268 | CNR1, CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR | cannabinoid receptor 1 (brain) |
C00047211
|
| 51084 | CRYL1, GDH, lambda-CRY | crystallin, lambda 1 (EC:1.1.1.45) |
C00047211
|
| 1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00047211
|
| 1453 | CSNK1D, ASPS, CKIdelta, FASPS2, HCKID | casein kinase 1, delta (EC:2.7.11.1 2.7.11.26) |
C00047211
|
| 1490 | CTGF, CCN2, HCS24, IGFBP8, NOV2 | connective tissue growth factor |
C00047211
|
| 54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00047211
|
| 1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00047211
|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00047211
|
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00047211
|
| 1591 | CYP24A1, CP24, CYP24, HCAI, P450-CC24 | cytochrome P450, family 24, subfamily A, polypeptide 1 (EC:1.14.13.126) |
C00047211
|
| 1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00047211
|
| 1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00047211
|
| 1572 | CYP2F1, C2F1, CYP2F | cytochrome P450, family 2, subfamily F, polypeptide 1 (EC:1.14.14.1) |
C00047211
|
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00047211
|
| 3491 | CYR61, CCN1, GIG1, IGFBP10 | cysteine-rich, angiogenic inducer, 61 |
C00047211
|
| 1605 | DAG1, 156DAG, A3a, AGRNR, DAG, MDDGC7, MDDGC9 | dystroglycan 1 (dystrophin-associated glycoprotein 1) |
C00047211
|
| 1634 | DCN, CSCD, DSPG2, PG40, PGII, PGS2, SLRR1B | decorin |
C00047211
|
| 10522 | DEAF1, NUDR, SPN, ZMYND5 | DEAF1 transcription factor |
C00047211
|
| 8560 | DEGS1, DEGS, DEGS-1, DES1, Des-1, FADS7, MLD | delta(4)-desaturase, sphingolipid 1 (EC:1.14.-.-) |
C00047211
|
| 1734 | DIO2, 5DII, D2, DIOII, SelY, TXDI2 | deiodinase, iodothyronine, type II (EC:1.97.1.10) |
C00047211
|
| 8847 | DLEU2, 1B4, BCMSUN, DLB2, LEU2, LINC00022, MIR15AHG, NCRNA00022, RFP2OS, TRIM13OS | deleted in lymphocytic leukemia 2 (non-protein coding) |
C00047211
|
| 25822 | DNAJB5, Hsc40 | DnaJ (Hsp40) homolog, subfamily B, member 5 |
C00047211
|
| 10059 | DNM1L, DLP1, DRP1, DVLP, DYMPLE, EMPF, HDYNIV | dynamin 1-like (EC:3.6.5.5) |
C00047211
|
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00047211
|
| 1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00047211
|
| 1959 | EGR2, AT591, CMT1D, CMT4E, KROX20 | early growth response 2 |
C00047211
|
| 83939 | EIF2A, EIF-2A, MST089, MSTP004, MSTP089 | eukaryotic translation initiation factor 2A, 65kDa |
C00047211
|
| 1965 | EIF2S1, EIF-2, EIF-2A, EIF-2alpha, EIF2, EIF2A | eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
C00047211
|
| 8672 | EIF4G3, eIF-4G_3, eIF4G_3, eIF4GII | eukaryotic translation initiation factor 4 gamma, 3 |
C00047211
|
| 1983 | EIF5, EIF-5, EIF-5A | eukaryotic translation initiation factor 5 |
C00047211
|
| 2000 | ELF4, ELFR, MEF | E74-like factor 4 (ets domain transcription factor) |
C00047211
|
| 2002 | ELK1 | ELK1, member of ETS oncogene family |
C00047211
|
| 8507 | ENC1, CCL28, ENC-1, KLHL35, KLHL37, NRPB, PIG10, TP53I10 | ectodermal-neural cortex 1 (with BTB domain) |
C00047211
|
| 2021 | ENDOG | endonuclease G |
C00047211
|
| 1833 | EPYC, DSPG3, PGLB, Pg-Lb, SLRR3B | epiphycan |
C00047211
|
| 2064 | ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) |
C00047211
|
| 2065 | ERBB3, ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 (EC:2.7.10.1) |
C00047211
|
| 2069 | EREG, ER | epiregulin |
C00047211
|
| 2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00047211
|
| 2132 | EXT2, SOTV | exostosin glycosyltransferase 2 (EC:2.4.1.225 2.4.1.224) |
C00047211
|
| 2161 | F12, HAE3, HAEX, HAF | coagulation factor XII (Hageman factor) (EC:3.4.21.38) |
C00047211
|
| 2147 | F2, PT, RPRGL2, THPH1 | coagulation factor II (thrombin) (EC:3.4.21.5) |
C00047211
|
| 355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00047211
|
| 356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00047211
|
| 2194 | FASN, FAS, OA-519, SDR27X1 | fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) |
C00047211
|
| 2091 | FBL, FIB, FLRN, RNU3IP1 | fibrillarin |
C00047211
|
| 10875 | FGL2, T49, pT49 | fibrinogen-like 2 |
C00047211
|
| 2272 | FHIT, AP3Aase, FRA3B | fragile histidine triad (EC:3.6.1.29) |
C00047211
|
| 2277 | FIGF, VEGF-D, VEGFD | c-fos induced growth factor (vascular endothelial growth factor D) |
C00047211
|
| 2332 | FMR1, FMRP, FRAXA, POF, POF1 | fragile X mental retardation 1 |
C00047211
|
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00047211
|
| 2444 | FRK, GTK, PTK5, RAK | fyn-related kinase (EC:2.7.10.2) |
C00047211
|
| 10468 | FST, FS | follistatin |
C00047211
|
| 2526 | FUT4, CD15, ELFT, FCT3A, FUC-TIV, FUTIV, LeX, SSEA-1 | fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) (EC:2.4.1.-) |
C00047211
|
| 8324 | FZD7, FzE3 | frizzled family receptor 7 |
C00047211
|
| 2589 | GALNT1, GALNAC-T1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) (EC:2.4.1.41) |
C00047211
|
| 2619 | GAS1 | growth arrest-specific 1 |
C00047211
|
| 9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00047211
|
| 8733 | GPAA1, GAA1, hGAA1 | glycosylphosphatidylinositol anchor attachment 1 |
C00047211
|
| 2861 | GPR37, EDNRBL, PAELR, hET(B)R-LP | G protein-coupled receptor 37 (endothelin receptor type B-like) |
C00047211
|
| 2896 | GRN, CLN11, GEP, GP88, PCDGF, PEPI, PGRN | granulin |
C00047211
|
| 2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00047211
|
| 1839 | HBEGF, DTR, DTS, DTSF, HEGFL | heparin-binding EGF-like growth factor |
C00047211
|
| 3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00047211
|
| 3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00047211
|
| 3188 | HNRNPH2, FTP3, HNRPH', HNRPH2, hnRNPH' | heterogeneous nuclear ribonucleoprotein H2 (H') |
C00047211
|
| 10553 | HTATIP2, CC3, SDR44U1, TIP30 | HIV-1 Tat interactive protein 2, 30kDa (EC:1.1.1.-) |
C00047211
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00047211
|
| 8870 | IER3, DIF-2, DIF2, GLY96, IEX-1, IEX-1L, IEX1, PRG1 | immediate early response 3 |
C00047211
|
| 2537 | IFI6, 6-16, FAM14C, G1P3, IFI-6-16, IFI616 | interferon, alpha-inducible protein 6 |
C00047211
|
| 3440 | IFNA2, IFN-alphaA, IFNA, IFNA2B, INFA2 | interferon, alpha 2 |
C00047211
|
| 3458 | IFNG, IFG, IFI | interferon, gamma |
C00047211
|
| 11020 | IFT27, RABL4, RAYL | intraflagellar transport 27 homolog (Chlamydomonas) |
C00047211
|
| 3487 | IGFBP4, BP-4, HT29-IGFBP, IBP4, IGFBP-4 | insulin-like growth factor binding protein 4 |
C00047211
|
| 3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00047211
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00047211
|
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00047211
|
| 3572 | IL6ST, CD130, CDW130, GP130, IL-6RB | interleukin 6 signal transducer (gp130, oncostatin M receptor) |
C00047211
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00047211
|
| 8826 | IQGAP1, HUMORFA01, SAR1, p195 | IQ motif containing GTPase activating protein 1 |
C00047211
|
| 3667 | IRS1, HIRS-1 | insulin receptor substrate 1 |
C00047211
|
| 3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00047211
|
| 3694 | ITGB6 | integrin, beta 6 |
C00047211
|
| 3705 | ITPK1, ITRPK1 | inositol-tetrakisphosphate 1-kinase (EC:2.7.1.134 2.7.1.159) |
C00047211
|
| 3708 | ITPR1, INSP3R1, IP3R, IP3R1, SCA15, SCA16, SCA29 | inositol 1,4,5-trisphosphate receptor, type 1 |
C00047211
|
| 23189 | KANK1, ANKRD15, CPSQ2, KANK | KN motif and ankyrin repeat domains 1 |
C00047211
|
| 23313 | C22orf9 | KIAA0930 |
C00047211
|
| 3845 | KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2 | Kirsten rat sarcoma viral oncogene homolog |
C00047211
|
| 3860 | KRT13, CK13, K13 | keratin 13 |
C00047211
|
| 200185 | KRTCAP2, KCP2 | keratinocyte associated protein 2 |
C00047211
|
| 3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) |
C00047211
|
| 3958 | LGALS3, CBP35, GAL3, GALBP, GALIG, L31, LGALS2, MAC2 | lectin, galactoside-binding, soluble, 3 |
C00047211
|
| 4008 | LMO7, FBX20, FBXO20, LOMP | LIM domain 7 |
C00047211
|
| 9404 | LPXN, LDPL | leupaxin |
C00047211
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00047211
|
| 1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00047211
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00047211
|
| 5598 | MAPK7, BMK1, ERK4, ERK5, PRKM7 | mitogen-activated protein kinase 7 (EC:2.7.11.24) |
C00047211
|
| 4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00047211
|
| 4192 | MDK, ARAP, MK, NEGF2 | midkine (neurite growth-promoting factor 2) |
C00047211
|
| 406991 | MIR21, MIRN21, hsa-mir-21, miR-21, miRNA21 | microRNA 21 |
C00047211
|
| 4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00047211
|
| 4322 | MMP13, CLG3, MANDP1 | matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) |
C00047211
|
| 3110 | MNX1, HB9, HLXB9, HOXHB9, SCRA1 | motor neuron and pancreas homeobox 1 |
C00047211
|
| 4350 | MPG, AAG, ADPG, APNG, CRA36.1, MDG, Mid1, PIG11, PIG16, anpg | N-methylpurine-DNA glycosylase (EC:3.2.2.21) |
C00047211
|
| 51081 | MRPS7, MRP-S, MRP-S7, RP-S7, RPMS7, S7mt, bMRP27a | mitochondrial ribosomal protein S7 |
C00047211
|
| 4437 | MSH3, DUP, MRP1 | mutS homolog 3 |
C00047211
|
| 4481 | MSR1, CD204, SCARA1, SR-A, SRA, phSR1, phSR2 | macrophage scavenger receptor 1 |
C00047211
|
| 23788 | MTCH2, MIMP, SLC25A50 | mitochondrial carrier 2 |
C00047211
|
| 9108 | MTMR7 | myotubularin related protein 7 (EC:3.1.3.-) |
C00047211
|
| 4084 | MXD1, BHLHC58, MAD, MAD1 | MAX dimerization protein 1 |
C00047211
|
| 83463 | MXD3, BHLHC13, MAD3, MYX | MAX dimerization protein 3 |
C00047211
|
| 4638 | MYLK, AAT7, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK | myosin light chain kinase (EC:2.7.11.18) |
C00047211
|
| 4077 | NBR1, 1A1-3B, M17S2 | neighbor of BRCA1 gene 1 |
C00047211
|
| 4751 | NEK2, HsPK21, NEK2A, NLK1 | NIMA-related kinase 2 (EC:2.7.11.1) |
C00047211
|
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00047211
|
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00047211
|
| 4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00047211
|
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00047211
|
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00047211
|
| 4856 | NOV, CCN3, IBP-9, IGFBP-9, IGFBP9, NOVh | nephroblastoma overexpressed |
C00047211
|
| 4886 | NPY1R, NPY1-R, NPYR | neuropeptide Y receptor Y1 |
C00047211
|
| 10062 | NR1H3, LXR-a, LXRA, RLD-1 | nuclear receptor subfamily 1, group H, member 3 |
C00047211
|
| 64710 | NUCKS1, NUCKS | nuclear casein kinase and cyclin-dependent kinase substrate 1 |
C00047211
|
| 4986 | OPRK1, K-OR-1, KOR, KOR-1, OPRK | opioid receptor, kappa 1 |
C00047211
|
| 4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00047211
|
| 5036 | PA2G4, EBP1, HG4-1, p38-2G4 | proliferation-associated 2G4, 38kDa |
C00047211
|
| 5069 | PAPPA, ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1 | pregnancy-associated plasma protein A, pappalysin 1 (EC:3.4.24.79) |
C00047211
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00047211
|
| 5077 | PAX3, CDHS, HUP2, WS1, WS3 | paired box 3 |
C00047211
|
| 84759 | PCGF1, 2010002K04Rik, NSPC1, RNF3A-2, RNF68 | polycomb group ring finger 1 |
C00047211
|
| 5111 | PCNA | proliferating cell nuclear antigen |
C00047211
|
| 5134 | PDCD2, RP8, ZMYND7 | programmed cell death 2 |
C00047211
|
| 5297 | PI4KA, PI4K-ALPHA, PIK4CA, pi4K230 | phosphatidylinositol 4-kinase, catalytic, alpha (EC:2.7.1.67) |
C00047211
|
| 5283 | PIGH, GPI-H | phosphatidylinositol glycan anchor biosynthesis, class H (EC:2.4.1.198) |
C00047211
|
| 10026 | PIGK, GPI8 | phosphatidylinositol glycan anchor biosynthesis, class K (EC:3.-.-.-) |
C00047211
|
| 5289 | PIK3C3, VPS34, hVps34 | phosphatidylinositol 3-kinase, catalytic subunit type 3 (EC:2.7.1.137) |
C00047211
|
| 5294 | PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma, p120-PI3K | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153) |
C00047211
|
| 29990 | PILRB, FDFACT1, FDFACT2 | paired immunoglobin-like type 2 receptor beta |
C00047211
|
| 5319 | PLA2G1B, PLA2, PLA2A, PPLA2 | phospholipase A2, group IB (pancreas) (EC:3.1.1.4) |
C00047211
|
| 5329 | PLAUR, CD87, U-PAR, UPAR, URKR | plasminogen activator, urokinase receptor |
C00047211
|
| 23646 | PLD3, HU-K4, HUK4 | phospholipase D family, member 3 (EC:3.1.4.4) |
C00047211
|
| 5350 | PLN, CMD1P, CMH18, PLB | phospholamban |
C00047211
|
| 5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00047211
|
| 10908 | PNPLA6, NTE, NTEMND, SPG39, iPLA2delta, sws | patatin-like phospholipase domain containing 6 (EC:3.1.1.5) |
C00047211
|
| 56342 | PPAN, BXDC3, SSF, SSF-1, SSF1, SSF2 | peter pan homolog (Drosophila) |
C00047211
|
| 5532 | PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta | protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16) |
C00047211
|
| 10549 | PRDX4, AOE37-2, PRX-4 | peroxiredoxin 4 (EC:1.11.1.15) |
C00047211
|
| 5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00047211
|
| 5590 | PRKCZ, PKC-ZETA, PKC2 | protein kinase C, zeta (EC:2.7.11.13) |
C00047211
|
| 5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00047211
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00047211
|
| 5764 | PTN, HARP, HBGF8, HBNF, NEGF1 | pleiotrophin |
C00047211
|
| 7803 | PTP4A1, HH72, PRL-1, PRL1, PTP(CAAX1), PTPCAAX1 | protein tyrosine phosphatase type IVA, member 1 (EC:3.1.3.48) |
C00047211
|
| 11156 | PTP4A3, PRL-3, PRL-R, PRL3 | protein tyrosine phosphatase type IVA, member 3 (EC:3.1.3.48) |
C00047211
|
| 2889 | RAPGEF1, C3G, GRF2 | Rap guanine nucleotide exchange factor (GEF) 1 |
C00047211
|
| 5919 | RARRES2, HP10433, TIG2 | retinoic acid receptor responder (tazarotene induced) 2 |
C00047211
|
| 5933 | RBL1, CP107, PRB1, p107 | retinoblastoma-like 1 (p107) |
C00047211
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00047211
|
| 5972 | REN, HNFJ2 | renin (EC:3.4.23.15) |
C00047211
|
| 51065 | RPS27L | ribosomal protein S27-like |
C00047211
|
| 6283 | S100A12, CAAF1, CAGC, CGRP, ENRAGE, MRP-6, MRP6, p6 | S100 calcium binding protein A12 |
C00047211
|
| 6275 | S100A4, 18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98 | S100 calcium binding protein A4 |
C00047211
|
| 6278 | S100A7, PSOR1, S100A7c | S100 calcium binding protein A7 |
C00047211
|
| 6303 | SAT1, DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1 | spermidine/spermine N1-acetyltransferase 1 (EC:2.3.1.57) |
C00047211
|
| 90701 | SEC11C, SEC11L3, SPC21, SPCS4C | SEC11 homolog C (S. cerevisiae) (EC:3.4.21.89) |
C00047211
|
| 5272 | SERPINB9, CAP-3, CAP3, PI-9, PI9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
C00047211
|
| 5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00047211
|
| 5270 | SERPINE2, GDN, GDNPF, PI-7, PI7, PN-1, PN1, PNI | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
C00047211
|
| 9792 | SERTAD2, Sei-2, TRIP-Br2 | SERTA domain containing 2 |
C00047211
|
| 140885 | SIRPA, BIT, CD172A, MFR, MYD-1, P84, PTPNS1, SHPS1, SIRP | signal-regulatory protein alpha (EC:3.1.3.48) |
C00047211
|
| 6503 | SLA, SLA1, SLAP | Src-like-adaptor |
C00047211
|
| 6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00047211
|
| 6583 | SLC22A4, OCTN1 | solute carrier family 22 (organic cation/zwitterion transporter), member 4 |
C00047211
|
| 9481 | SLC25A27, UCP4 | solute carrier family 25, member 27 |
C00047211
|
| 6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00047211
|
| 6528 | SLC5A5, NIS, TDH1 | solute carrier family 5 (sodium/iodide cotransporter), member 5 |
C00047211
|
| 8140 | SLC7A5, 4F2LC, CD98, D16S469E, E16, LAT1, MPE16, hLAT1 | solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
C00047211
|
| 57223 | SMEK2, FLFL2, PP4R3B, PSY2, smk1 | SMEK homolog 2, suppressor of mek1 (Dictyostelium) |
C00047211
|
| 6606 | SMN1, BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3, SMA4, SMA@, SMN, SMNT, T-BCD541, TDRD16A | survival of motor neuron 1, telomeric |
C00047211
|
| 22938 | SNW1, Bx42, NCOA-62, PRPF45, Prp45, SKIIP, SKIP | SNW domain containing 1 |
C00047211
|
| 8651 | SOCS1, CIS1, CISH1, JAB, SOCS-1, SSI-1, SSI1, TIP3 | suppressor of cytokine signaling 1 |
C00047211
|
| 6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00047211
|
| 6654 | SOS1, GF1, GGF1, GINGF, HGF, NS4 | son of sevenless homolog 1 (Drosophila) |
C00047211
|
| 6742 | SSBP1, Mt-SSB, SOSS-B1, SSBP, mtSSB | single-stranded DNA binding protein 1, mitochondrial |
C00047211
|
| 6489 | ST8SIA1, GD3S, SIAT8, SIAT8-A, SIAT8A, ST8SiaI | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 (EC:2.4.99.8) |
C00047211
|
| 6788 | STK3, KRS1, MST2 | serine/threonine kinase 3 (EC:2.7.11.1) |
C00047211
|
| 2054 | STX2, EPIM, EPM, STX2A, STX2B, STX2C | syntaxin 2 |
C00047211
|
| 6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00047211
|
| 6820 | SULT2B1, HSST2 | sulfotransferase family, cytosolic, 2B, member 1 (EC:2.8.2.2) |
C00047211
|
| 6827 | SUPT4H1, SPT4, SPT4H, SUPT4H | suppressor of Ty 4 homolog 1 (S. cerevisiae) |
C00047211
|
| 11346 | SYNPO | synaptopodin |
C00047211
|
| 6867 | TACC1, Ga55 | transforming, acidic coiled-coil containing protein 1 |
C00047211
|
| 57252 |
C00047211
|
||
| 7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00047211
|
| 7039 | TGFA, TFGA | transforming growth factor, alpha |
C00047211
|
| 7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00047211
|
| 7056 | THBD, AHUS6, BDCA3, CD141, THPH12, THRM, TM | thrombomodulin |
C00047211
|
| 7070 | THY1, CD90 | Thy-1 cell surface antigen |
C00047211
|
| 7082 | TJP1, ZO-1 | tight junction protein 1 |
C00047211
|
| 51768 | TM7SF3 | transmembrane 7 superfamily member 3 |
C00047211
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00047211
|
| 7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00047211
|
| 8797 | TNFRSF10A, APO2, CD261, DR4, TRAILR-1, TRAILR1 | tumor necrosis factor receptor superfamily, member 10a |
C00047211
|
| 8795 | TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9 | tumor necrosis factor receptor superfamily, member 10b |
C00047211
|
| 4982 | TNFRSF11B, OCIF, OPG, TR1 | tumor necrosis factor receptor superfamily, member 11b |
C00047211
|
| 943 | TNFRSF8, CD30, D1S166E, Ki-1 | tumor necrosis factor receptor superfamily, member 8 |
C00047211
|
| 8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00047211
|
| 8600 | TNFSF11, CD254, ODF, OPGL, OPTB2, RANKL, TRANCE, hRANKL2, sOdf | tumor necrosis factor (ligand) superfamily, member 11 |
C00047211
|
| 7134 | TNNC1, CMD1Z, CMH13, TN-C, TNC, TNNC | troponin C type 1 (slow) |
C00047211
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00047211
|
| 9537 | TP53I11, PIG11 | tumor protein p53 inducible protein 11 |
C00047211
|
| 8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00047211
|
| 10426 | TUBGCP3, 104p, GCP3, Grip104, SPBC98, Spc98, Spc98p | tubulin, gamma complex associated protein 3 |
C00047211
|
| 7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00047211
|
| 7298 | TYMS, HST422, TMS, TS | thymidylate synthetase (EC:2.1.1.45) |
C00047211
|
| 7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00047211
|
| 54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00047211
|
| 7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00047211
|
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00047211
|
| 7436 | VLDLR, CARMQ1, CHRMQ1, VLDLRCH | very low density lipoprotein receptor |
C00047211
|
| 7447 | VSNL1, HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1 | visinin-like 1 |
C00047211
|
| 10413 | YAP1, YAP, YAP2, YAP65, YKI | Yes-associated protein 1 |
C00047211
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| %606641 | Body mass index; bmi |
P37231
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #609338 | Carotid intimal medial thickness 1 |
P37231
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #114500 | Colorectal cancer; crc |
P84022
|
| #162800 | Cyclic neutropenia |
P08246
|
| #127750 | Dementia, lewy body; dlb |
P37840
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #614557 | Ehlers-danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; edskmh |
Q9NWM8
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #133239 | Esophageal cancer |
P04637
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #143100 | Huntington disease; hd |
P42858
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #612371 | Major affective disorder 7; mafd7 |
P17861
|
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
| #601665 | Obesity |
P32245
P37231 |
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
| #605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
| #168600 | Parkinson disease, late-onset; pd |
P37840
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
| H00033 | Adrenal carcinoma |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
|
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00409 | Type II diabetes mellitus |
P37231
(related)
|
| H00057 | Parkinson's disease (PD) |
P37840
(related)
|
| H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
Q13148
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D000647 | Amnesia |
C00047211
|
| D019970 | Cocaine-Related Disorders |
C00047211
|
| D056486 | Drug-Induced Liver Injury |
C00047211
|
| D005909 | Glioblastoma |
C00047211
|
| D006949 | Hyperlipidemias |
C00047211
|
| D007174 | Impulse Control Disorders |
C00047211
|
| D007249 | Inflammation |
C00047211
|
| D007859 | Learning Disorders |
C00047211
|
| D008223 | Lymphoma |
C00047211
|
| D008569 | Memory Disorders |
C00047211
|
| D009135 | Muscular Diseases |
C00047211
|
| D009336 | Necrosis |
C00047211
|
| D009410 | Nerve Degeneration |
C00047211
|
| D009422 | Nervous System Diseases |
C00047211
|
| D011041 | Poisoning |
C00047211
|
| D013226 | Status Epilepticus |
C00047211
|